SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
悦耳诗筠
Lv5
820 积分
2023-09-01 加入
最近求助
最近应助
互助留言
Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate
8天前
已完结
Efficacy of targeted therapy in patients with non-small cell lung cancer harboring very rare mutations in EGFR exon 18
20天前
已关闭
EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors
22天前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
22天前
已完结
表皮生长因子受体罕见亚型敏感突变阳性肺癌的精准治疗
22天前
已完结
First-in-human phase I study of BEBT-109 in previously treated EGFR exon 20 insertion-mutated advanced non-small cell lung cancer
28天前
已完结
First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations: The UNICORN Phase 2 Nonrandomized Clinical Trial
29天前
已完结
First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations The UNICORN Phase 2 Nonrandomized Clinical Trial
1个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer
1个月前
已完结
没有进行任何应助
感谢,点赞,速度真快,帮大忙了
8天前
不需要了【积分已退回】
20天前
感谢,点赞,速度真快,帮大忙了
22天前
感谢,点赞,速度真快,帮大忙了
22天前
感谢,点赞,速度真快,帮大忙了
22天前
感谢,点赞,速度真快,帮大忙了
28天前
感谢,点赞,帮大忙了
29天前
感谢,点赞,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快,帮大忙了
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论